US Stock MarketDetailed Quotes
IBIO iBio Inc
- 1.9300
- -0.0900-4.46%
Close Apr 15 16:00 ET
16.43MMarket Cap-428P/E (TTM)
2.0400High1.9000Low208.62KVolume2.0100Open2.0200Pre Close406.49KTurnover3.32%Turnover RatioLossP/E (Static)8.52MShares26.200052wk High1.79P/B12.13MFloat Cap1.021452wk Low--Dividend TTM6.28MShs Float30300.0000Historical High--Div YieldTTM6.93%Amplitude1.0214Historical Low1.9480Avg Price1Lot Size
About iBio Inc Company
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.
Company Profile
SymbolIBIO
Company NameiBio Inc
Listing DateJan 4, 2011
Founded1993
CEODr. Martin B. Brenner
MarketAMEX
Employees23
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address8800 HSC Parkway
CityBryan
ProvinceTexas
CountryUnited States of America
Zip Code77807
Phone1-302-355-0650
Websitehttp://www.ibioinc.com
Company Executives
- Name
- Position
- Salary
- Dr. Martin B. Brenner
- Chief Executive Officer and Chief Scientific Officer
- 1.07M
- Felipe Duran
- Chief Financial Officer and Principal Accounting Officer
- 699.66K
- William D. Clark
- Chairman of the Board
- 73.01K
- Dr. Alexandra Kropotova, M.D.
- Independent Director
- 52.50K
- Evert B. Schimmelpennink
- Independent Director
- 57.50K
- Dr. Linda Washington Arrong, M.D.
- Independent Director
- 63.50K
- Gary L. Sender
- Independent Director
- 71.41K
- General James T. Hill, (Ret.)
- Independent Director
- 55.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg